Intracranial Pressure monitoring market will grow at a 6.2% CAGR

Diagnostic procedures to determine whether the pressure inside the head is high or low use intracranial pressure (ICP) monitoring devices. The monitor determines the head pressure and transmits the results to a recording device. The two types of methods most frequently used are invasive and noninvasive. Due to its high accuracy, the invasive method is one of them that doctors use most frequently. The market for intracranial pressure monitoring will grow at a strong CAGR of 6.2%, from a value of $1.38 billion in 2021 to $2.37 billion by 2030.

Key Industry Drivers

The high prevalence of head and brain injuries and other diseases that necessitate regular monitoring of the patient’s so that appropriate medical attention can be given to the patient promptly is the main factor that will impact the growth of the market.

 The demand for intracranial pressure monitoring is also anticipate to grow, which is anticipate to accelerate growth in the market. This is due to the growing burden of neurodegenerative diseases like dementia, Alzheimer’s, Parkinson’s, and others, as well as the rising geriatric population, who are prone to head injuries and neurodegenerative diseases. For instance, the World Health Organization reported in September 2021 that approximately 55 million people globally were living with dementia and that there are roughly 10 million new cases each year.

Additionally, the increasing public awareness of neurodegenerative and other brain and head injuries and diseases combined with technological developments in the intracranial pressure monitoring field are anticipated to positively affect the studied market as both of these factors are predicted to increase the acceptance of advanced devices, which is predicted to accelerate market growth.

Throughout the forecast period, the market will be constrain by a lack of qualified professionals and the high cost of intracranial pressure monitoring.

Segmentation analysis

Technology Insights

With the largest revenue share of 80.9% in 2021, the invasive techniques segment ruled the market for devices. This is because invasive ICP measurements can be carry out at a variety of intracranial anatomical sites (i.e., intraventricular, intraparenchymal, epidural, subdural, and subarachnoidal). External ventricular drain and micro-transducer ICP monitoring are the two categories of invasive techniques that are currently being use.

Application Insights

With a revenue share of roughly 31.6% in 2021, the traumatic brain injury segment was the market leader for intracranial pressure monitoring devices. Accurate ICP assessment is a key component of treatment success. In addition, it is anticipate that technological developments will fuel market expansion in the years to come.

Regional Insights

In 2021, North America ruled the market with a share of 37.6% in. The global market for intracranial pressure monitoring devices. The rising availability of technologically advance devices, rising demand for minimally invasive surgeries, and increase adoption. Of noninvasive ICP monitoring techniques are some of. The major factors anticipate to support market growth in this region. In addition to the rising number of trauma cases, the market for intracranial pressure monitoring devices is anticipate to be driven by. The rising prevalence of migraine, stroke, and other neurological disorders.

Key Players analysis

The leading companies in the global devices market include Medtronic plc, Integra LifeScience Corporation, Vittamed, Vivonics Inc.. Orsan Medical Technologies, HeadSense Medical, Codman & Shurtleff (Johnson & Johnson, DePuy Synthes Companies), and Spiegelberg.

These market players are actively developing novel innovations in. The space and pursuing tactical projects like partnerships, mergers, and acquisitions. To enhance their market share in the overall intracranial pressure (ICP) monitoring devices market.

Recent Development

Longeviti Neuro Solutions introduced Longeviti ClearFit Cover. It is use to replace remove cranial bone after a neurosurgical procedure. Allowing neurosurgeons to view neuroanatomy using ultrasound imaging after brain surgery and enabling long-term patient monitoring.


Leave a Reply

Your email address will not be published. Required fields are marked *